Isoflurane Promotes Non-Small Cell Lung Cancer Malignancy by Activating the Akt-Mammalian Target of Rapamycin (mTOR) Signaling Pathway

BACKGROUND: Lung cancer is one of the leading causes of cancer mortalities worldwide, and non-small cell lung cancer (NSCLC) accounts for the majority of all lung cancer cases. Surgery remains one of the front-line treatment options for NSCLC, but events within the perioperative period were found to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wenhua, Shao, Xueqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2016
Materias:
Lab/In Vitro Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142580/
https://www.ncbi.nlm.nih.gov/pubmed/27897153
http://dx.doi.org/10.12659/MSM.898434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142580/
https://www.ncbi.nlm.nih.gov/pubmed/27897153
http://dx.doi.org/10.12659/MSM.898434

Ejemplares similares